Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

The epidemiology of psychiatric disorders in Africa: a scoping review.

Tytuł:
The epidemiology of psychiatric disorders in Africa: a scoping review.
Autorzy:
Greene MC; Program on Forced Migration and Health, Heilbrunn Department of Population and Family Health, Columbia University Mailman School of Public Health, New York, NY, USA.
Yangchen T; Division of Translational Epidemiology, Department of Psychiatry, New York State Psychiatric Institute, New York, NY, USA.
Lehner T; New York Genome Center, New York, NY, USA; Division of Molecular Imaging and Neuropathology, New York State Psychiatric Institute, New York, NY, USA.
Sullivan PF; Center for Psychiatric Genomics, Department of Genetics, University of North Carolina School of Medicine, Chapel Hill, NC, USA.
Pato CN; Institute for Genomic Health, SUNY Downstate, Health Science University, Brooklyn, NY, USA.
McIntosh A; Division of Psychiatry, University of Edinburgh, Royal Edinburgh Hospital, Edinburgh, UK.
Walters J; MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Cardiff, UK.
Gouveia LC; Department of Mental Health, Ministry of Health-Mozambique, Maputo, Mozambique.
Msefula CL; Pathology Department, College of Medicine, University of Malawi, Chichiri, Blantyre, Malawi.
Fumo W; Department of Mental Health, Ministry of Health-Mozambique, Maputo, Mozambique.
Sheikh TL; Department of Psychiatry, College of Medical Sciences, Ahmadu Bello University, Zaria, Nigeria.
Stockton MA; Division of Translational Epidemiology, Department of Psychiatry, New York State Psychiatric Institute, New York, NY, USA; Columbia University Vagelos College of Physicians and Surgeons; New York State Psychiatric Institute, New York, NY, USA.
Wainberg ML; Division of Translational Epidemiology, Department of Psychiatry, New York State Psychiatric Institute, New York, NY, USA; Columbia University Vagelos College of Physicians and Surgeons; New York State Psychiatric Institute, New York, NY, USA.
Weissman MM; Division of Translational Epidemiology, Department of Psychiatry, New York State Psychiatric Institute, New York, NY, USA; Columbia University Vagelos College of Physicians and Surgeons; New York State Psychiatric Institute, New York, NY, USA. Electronic address: .
Źródło:
The lancet. Psychiatry [Lancet Psychiatry] 2021 Aug; Vol. 8 (8), pp. 717-731. Date of Electronic Publication: 2021 Jun 08.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Review
Język:
English
Imprint Name(s):
Original Publication: Kidlington, Oxford : Elsevier, [2014]-
MeSH Terms:
Anxiety Disorders/*epidemiology
Mood Disorders/*epidemiology
Psychotic Disorders/*epidemiology
Substance-Related Disorders/*epidemiology
Africa/epidemiology ; Humans ; Prevalence
References:
Int J Environ Res Public Health. 2012 May;9(5):1748-56. (PMID: 22754470)
Popul Health Metr. 2016 May 05;14:18. (PMID: 27152093)
Acta Psychiatr Scand. 2007 Sep;116(3):182-8. (PMID: 17655559)
JAMA. 1996 Jul 24-31;276(4):293-9. (PMID: 8656541)
Addict Behav. 2020 Mar;102:106128. (PMID: 31865172)
BMC Med. 2019 Mar 21;17(1):65. (PMID: 30894161)
BMC Int Health Hum Rights. 2013 Apr 05;13:19. (PMID: 23561039)
World Psychiatry. 2009 Oct;8(3):131-9. (PMID: 19812742)
Addiction. 1993 Jun;88(6):791-804. (PMID: 8329970)
Arch Intern Med. 2006 May 22;166(10):1092-7. (PMID: 16717171)
J Abnorm Child Psychol. 1987 Dec;15(4):629-50. (PMID: 3437096)
JAMA Psychiatry. 2020 Sep 1;77(9):967-973. (PMID: 32401285)
PLoS One. 2018 Jun 7;13(6):e0198429. (PMID: 29879167)
J Clin Psychiatry. 1998;59 Suppl 20:22-33;quiz 34-57. (PMID: 9881538)
Arch Intern Med. 1998 Sep 14;158(16):1789-95. (PMID: 9738608)
World Psychiatry. 2007 Oct;6(3):168-76. (PMID: 18188442)
Health Soc Care Community. 2018 Jan;26(1):e143-e153. (PMID: 28868804)
Acta Psychiatr Scand Suppl. 1999;397:24-9. (PMID: 10470351)
Arch Gen Psychiatry. 1984 Oct;41(10):934-41. (PMID: 6089692)
J Affect Disord. 2004 May;80(1):1-10. (PMID: 15094252)
Child Psychiatry Hum Dev. 2018 Aug;49(4):659-671. (PMID: 29387998)
J Nerv Ment Dis. 2002 Sep;190(9):631-7. (PMID: 12357098)
Alcohol. 2018 Dec;73:37-44. (PMID: 30261452)
Nat Genet. 2013 Sep;45(9):984-94. (PMID: 23933821)
J Affect Disord. 2018 Feb;227:48-55. (PMID: 29053975)
Soc Psychiatry Psychiatr Epidemiol. 2003 Nov;38(11):625-31. (PMID: 14614550)
S Afr Med J. 2009 May;99(5 Pt 2):367-73. (PMID: 19588800)
Lancet. 1992 Jul 18;340(8812):137-40. (PMID: 1352565)
Arch Gen Psychiatry. 1984 Oct;41(10):931-3. (PMID: 6477053)
J Stud Alcohol. 2005 Jan;66(1):91-7. (PMID: 15830908)
BMC Med. 2005 Feb 12;3:5. (PMID: 15707502)
BMC Psychiatry. 2014 Nov 18;14:315. (PMID: 25406929)
AAS Open Res. 2018 Apr 18;1:3. (PMID: 30714022)
PLoS One. 2013;8(3):e58067. (PMID: 23469262)
Ann Gen Psychiatry. 2007 Feb 10;6:6. (PMID: 17291353)
BMC Psychiatry. 2017 Jan 18;17(1):30. (PMID: 28100210)
Afr J Psychiatry (Johannesbg). 2011 Mar;14(1):30-7. (PMID: 21509408)
Acta Psychiatr Scand. 2010 Jan;121(1):71-4. (PMID: 19681770)
BMC Med Res Methodol. 2018 Nov 19;18(1):143. (PMID: 30453902)
Addiction. 2008 Jun;103(6):1039-47. (PMID: 18373724)
Schizophr Res. 2000 Jun 16;43(2-3):117-23. (PMID: 10858630)
Addict Sci Clin Pract. 2017 Jan 6;12(1):3. (PMID: 28057079)
JAMA. 2008 Nov 5;300(17):2054-6. (PMID: 18984895)
Glob Health Action. 2013 Jan 18;6:1-9. (PMID: 23336621)
Science. 2006 Dec 8;314(5805):1603-6. (PMID: 17158329)
Soc Psychiatry Psychiatr Epidemiol. 2018 Dec;53(12):1325-1337. (PMID: 30159723)
Epidemiol Psichiatr Soc. 2009 Jan-Mar;18(1):23-33. (PMID: 19378696)
Pan Afr Med J. 2017 Nov 24;28:262. (PMID: 29881505)
J Nerv Ment Dis. 1992 Feb;180(2):111-6. (PMID: 1737972)
Psychol Med. 1992 May;22(2):465-86. (PMID: 1615114)
Epidemiol Psychiatr Sci. 2015 Jun;24(3):210-26. (PMID: 25720357)
Arch Gen Psychiatry. 2007 Mar;64(3):305-15. (PMID: 17339519)
S Afr Med J. 2009 May;99(5 Pt 2):339-44. (PMID: 19588796)
Acta Psychiatr Scand Suppl. 1999;397:11-7. (PMID: 10470349)
Arch Gen Psychiatry. 2005 Jun;62(6):593-602. (PMID: 15939837)
BMC Psychiatry. 2015 Dec 09;15:309. (PMID: 26651332)
Nat Med. 2003 Jul;9(7):839-43. (PMID: 12835701)
J Psychiatry. 2014 Nov;17(6):. (PMID: 25914902)
Nat Rev Genet. 2018 Mar;19(3):175-185. (PMID: 29151588)
Soc Psychiatry Psychiatr Epidemiol. 2004 Jun;39(6):442-7. (PMID: 15205728)
Science. 2020 Jan 31;367(6477):569-573. (PMID: 32001654)
Ann Intern Med. 2018 Oct 2;169(7):467-473. (PMID: 30178033)
Public Health. 2006 Jun;120(6):534-42. (PMID: 16684549)
Int J Ment Health Syst. 2018 Apr 03;12:12. (PMID: 29632551)
Aging Ment Health. 2021 Jun;25(6):1035-1041. (PMID: 32252543)
PLoS One. 2019 Oct 24;14(10):e0223970. (PMID: 31647827)
J Child Psychol Psychiatry. 1997 Jul;38(5):581-6. (PMID: 9255702)
Lancet. 2007 Sep 22;370(9592):1055-60. (PMID: 17889244)
Arch Gen Psychiatry. 1994 Jan;51(1):8-19. (PMID: 8279933)
J Health Soc Behav. 1974 Dec;15(4):289-99. (PMID: 4455732)
J Affect Disord. 2005 Aug;87(2-3):193-201. (PMID: 15913783)
Psychol Med. 1996 Sep;26(5):997-1007. (PMID: 8878332)
Encephale. 2019 Sep;45(4):367-370. (PMID: 29673721)
Lancet. 2007 Sep 15;370(9591):957-64. (PMID: 17869636)
BMJ Open. 2019 Feb 19;9(2):e025469. (PMID: 30782936)
Behav Sci. 1974 Jan;19(1):1-15. (PMID: 4808738)
Lancet Psychiatry. 2017 Feb;4(2):136-145. (PMID: 28137381)
J Subst Abuse Treat. 1992;9(3):199-213. (PMID: 1334156)
Int J Drug Policy. 2019 Sep;71:103-112. (PMID: 31255918)
Int J Methods Psychiatr Res. 2004;13(2):122-39. (PMID: 15297907)
Lancet Neurol. 2014 Oct;13(10):1029-44. (PMID: 25231525)
Soc Psychiatry Psychiatr Epidemiol. 2002 Nov;37(11):537-43. (PMID: 12395144)
East Afr Med J. 2005 Jan;82(1):34-9. (PMID: 16122110)
Subst Abus. 2013;34(2):97-104. (PMID: 23577901)
Br J Psychiatry. 2006 May;188:465-71. (PMID: 16648534)
Soc Psychiatry Psychiatr Epidemiol. 2015 Nov;50(11):1609-40. (PMID: 26210739)
Acta Psychiatr Scand Suppl. 1999;397:18-23. (PMID: 10470350)
J Womens Health (Larchmt). 2011 Nov;20(11):1703-11. (PMID: 21777144)
J Gen Intern Med. 2001 Sep;16(9):606-13. (PMID: 11556941)
Curr Opin HIV AIDS. 2009 Jul;4(4):240-6. (PMID: 19532059)
Subst Abuse Treat Prev Policy. 2019 Sep 3;14(1):36. (PMID: 31481091)
Br J Psychiatry. 2008 Feb;192(2):112-7. (PMID: 18245026)
Prog Cardiovasc Dis. 2013 Nov-Dec;56(3):251-60. (PMID: 24267432)
Arch Gen Psychiatry. 1984 Oct;41(10):949-58. (PMID: 6332590)
East Mediterr Health J. 2009 Jan-Feb;15(1):65-75. (PMID: 19469428)
Cell. 2019 Oct 17;179(3):589-603. (PMID: 31607513)
Am J Trop Med Hyg. 2004 Aug;71(2 Suppl):268-78. (PMID: 15331847)
Compr Psychiatry. 2018 Feb;81:60-65. (PMID: 29268153)
Grant Information:
R01 MH104964 United States MH NIMH NIH HHS; MR/L010305/1 United Kingdom MRC_ Medical Research Council; MR/S035818/1 United Kingdom MRC_ Medical Research Council; R01 AA025947 United States AA NIAAA NIH HHS; R01 MH085548 United States MH NIMH NIH HHS; R01 MH123451 United States MH NIMH NIH HHS; D43 TW009675 United States TW FIC NIH HHS; T32 MH096724 United States MH NIMH NIH HHS; U19 MH113203 United States MH NIMH NIH HHS; MC_PC_MR/R01910X/1 United Kingdom MRC_ Medical Research Council
Entry Date(s):
Date Created: 20210611 Date Completed: 20210802 Latest Revision: 20230111
Update Code:
20240104
PubMed Central ID:
PMC9113063
DOI:
10.1016/S2215-0366(21)00009-2
PMID:
34115983
Czasopismo naukowe
This scoping review of population-based epidemiological studies was done to provide background information on the prevalences and distribution of psychiatric disorders in Africa for calls to broaden diversity in psychiatric genetic studies. We searched PubMed, EMBASE, and Web of Science to retrieve relevant literature in English, French, and Portuguese from Jan 1, 1984, to Aug 18, 2020. In 36 studies from 12 African countries, the lifetime prevalence ranged from 3·3% to 9·8% for mood disorders, from 5·7% to 15·8% for anxiety disorders, from 3·7% to 13·3% for substance use disorders, and from 1·0% to 4·4% for psychotic disorders. Although the prevalence of mood and anxiety disorders appears to be lower than that observed in research outside the continent, we identified similar distributions by gender, although not by age or urbanicity. This review reveals gaps in epidemiological research on psychiatric disorders and opportunities to leverage existing epidemiological and genetic research within Africa to advance our understanding of psychiatric disorders. Studies that are methodologically comparable but diverse in geographical context are needed to advance psychiatric epidemiology and provide a foundation for understanding environmental risk in genetic studies of diverse populations globally.
Competing Interests: Declaration of interests PFS reports personal fees and other from RBNC Therapeutics, outside the submitted work. AMcl reports personal fees from Janssen, personal fees from Illumina, grants from The Sackler Trust, outside the submitted work. JW reports grants from Takeda Pharmaceuticals, outside the submitted work. MMW reports research grants in the past 3 years from National Institute for Mental Health, Brain and Behavior Research Foundation, Templeton Foundation, and has received book royalties from the Perseus Press, Oxford Press, and APA Publishing. MMW has also received royalties on the social adjustment scale from Multihealth Systems. All other authors declare no competing interests. The Lancet Group takes a neutral position with respect to territorial claims in published tables, figures, and institutional affiliations.
(Copyright © 2021 Elsevier Ltd. All rights reserved.)

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies